Neurocrine Biosciences Reports First Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/23/2026
- Nasdaq reaches record high close, AI stocks rally
- Meta AI agent triggers heavy selloff in banks, insurers, and travel stocks
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
Neurocrine Biosciences (NBIX) Tops Q1 EPS by 28c, Revenues Beat
May 6, 2020 6:12 PM EDTNeurocrine Biosciences (NASDAQ: NBIX) reported Q1 EPS of $0.82, $0.28 better than the analyst estimate of $0.54. Revenue for the quarter came in at $237.1 million versus the consensus estimate of $223.87 million.
"First and foremost, I would like to thank our employees, healthcare providers and suppliers for their commitment and dedication in managing these tough... More
